BDBM314065 US9610264, Compound 2
SMILES: Fc1ccc(CC(=O)Nc2ccccc2C(=O)NCc2ccccc2)cc1
InChI Key: InChIKey=XRXLVYQWWZTNMN-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integrin α4β7 (Homo sapiens (Human)) | BDBM314065 (US9610264, Compound 2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 0.890 | n/a | n/a | n/a | n/a | n/a | n/a |
KFLP BIOTECH, LLC US Patent | Assay Description The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ... | US Patent US9610264 (2017) BindingDB Entry DOI: 10.7270/Q2KH0QD4 | |||||||||||
More data for this Ligand-Target Pair |